波替单抗(万珂)是第一个进入临床试验的蛋白酶体抑制剂。

Bortezonib (velcade) is the first proteasome inhibitor that has entered clinical trial.

youdao

波替单抗(万珂)是第一个进入临床试验的蛋白酶体抑制剂。

Bortezonib (velcade) is the first proteasome inhibitor that has entered clinical trial.

youdao